Article
Colistin Resistance in Acinetobacter baumannii MDR-ZJ06 Revealed by a Multiomics Approach.
Frontiers in cellular and infection microbiology - 1 Jan 2017
Hua Xiaoting, Liu Lilin, Fang Youhong, Shi Qiucheng, Li Xi, Chen Qiong, Shi Keren, Jiang Yan, Zhou Hua, Yu Yunsong
Abstract excerpt
Acinetobacter baumannii has emerged as an important opportunistic pathogen due to its ability to acquire resistance to most currently available antibiotics. Colistin is often considered as the last line of therapy for infections caused by multidrug-resistant A. baumannii (MDRAB). However, colistin-resistant A. baumannii strain has recently been reported. To explore how multiple drug-resistant A. baumannii...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
